Three people allegedly stabbed a man multiple times in outer Delhi’s Mangolpuri area, leaving him in a critical condition, police said on Wednesday. All the three accused — two of them minors — have ...
Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...
Alk-Abello AS (OCSE:ALK B) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 billion, and the earnings are expected to come in at $0.90 per ...
4hon MSN
It's "idle speculation" to discuss Supreme Court Justice Sonia Sotomayor retiring and having her seat filled before Trump ...
Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product ...
In the wake of rising incidents of firing by criminals to demand extortion money and due to gang rivalries, the Delhi Police has issued directions to local police to start checking hotels and guest ...
On Monday, Alaska Air Group, Inc. (ALK) stock saw a modest uptick, ending the day at $51.85 which represents a slight increase of $0.85 or 1.67% from the prior close of $51. The stock opened at $51.6 ...
ALK, a global specialty pharmaceutical company focused on allergy and allergic asthma, announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (ARS ...
Alaska Airlines overpaid for Hawaiian Holdings, acquiring a financially troubled airline. Click here to read why ALK stock is ...
Autostore Holdings Ltd. was the biggest leader among large stocks during the session, rising 9.6%, and ALK-Abello A/S Series B gained 7.2%. Borr Drilling Ltd. rounded out the top three leaders on ...
ALK-Abelló has acquired rights to Neffy adrenaline nasal spray in Europe and Canada, amongst other countries, from ARS ...
ARS Pharmaceuticals (SPRY) announced a licensing agreement with ALK-Abello A/S (AKBLF), that provides ALK exclusive rights to commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback